Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

SIRT7 inhibitor 97491

🥰Excellent
Catalog No. T39233Cas No. 1807758-81-1

SIRT7 inhibitor 97491 is an HDAC inhibitor with high specificity for SIRT7 (IC50 = 325 nM). SIRT7 inhibitor 97491 promotes apoptosis through caspase pathway.

SIRT7 inhibitor 97491

SIRT7 inhibitor 97491

🥰Excellent
Purity: 99.79%
Catalog No. T39233Cas No. 1807758-81-1
SIRT7 inhibitor 97491 is an HDAC inhibitor with high specificity for SIRT7 (IC50 = 325 nM). SIRT7 inhibitor 97491 promotes apoptosis through caspase pathway.
Pack SizePriceAvailabilityQuantity
1 mg$97In Stock
5 mg$247In Stock
10 mg$372In Stock
25 mg$629In Stock
50 mg$896In Stock
100 mg$1,220In Stock
1 mL x 10 mM (in DMSO)$272In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "SIRT7 inhibitor 97491"

Select Batch
Purity:99.79%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
SIRT7 inhibitor 97491 is an HDAC inhibitor with high specificity for SIRT7 (IC50 = 325 nM). SIRT7 inhibitor 97491 promotes apoptosis through caspase pathway.
Targets&IC50
SIRT7:325 nM
In vitro
SIRT7 inhibitor 97491 (1-10 μM) effectively reduces the proliferation of human uterine sarcoma MES-SA cells by over 50% at 5 and 10 μM after 72 hours, without cytotoxic effects on HEK293 human embryonic kidney cells after 24 hours of exposure, indicating selective action[1].
In vivo
The SIRT7 inhibitor 97491 (2 mg/kg; intraperitoneally injected; for 3 weeks, except on weekends) effectively suppresses tumor growth in xenograft mice[1]. Utilizing Balb/c nude mice (18-20 g; 6-8 weeks old) implanted with MES-SA cells[1], the dosage administered was 2 mg/kg via intraperitoneal injection over a three-week period, excluding weekends. The outcome was a significant inhibition of cancer growth in vivo.
Chemical Properties
Molecular Weight285.73
FormulaC15H12ClN3O
Cas No.1807758-81-1
SmilesNc1cccc(Nc2ncc(o2)-c2ccc(Cl)cc2)c1
Relative Density.1.354 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 500 mg/mL (1749.90 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.4998 mL17.4990 mL34.9981 mL174.9904 mL
5 mM0.7000 mL3.4998 mL6.9996 mL34.9981 mL
10 mM0.3500 mL1.7499 mL3.4998 mL17.4990 mL
20 mM0.1750 mL0.8750 mL1.7499 mL8.7495 mL
50 mM0.0700 mL0.3500 mL0.7000 mL3.4998 mL
100 mM0.0350 mL0.1750 mL0.3500 mL1.7499 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy SIRT7 inhibitor 97491 | purchase SIRT7 inhibitor 97491 | SIRT7 inhibitor 97491 cost | order SIRT7 inhibitor 97491 | SIRT7 inhibitor 97491 chemical structure | SIRT7 inhibitor 97491 in vivo | SIRT7 inhibitor 97491 in vitro | SIRT7 inhibitor 97491 formula | SIRT7 inhibitor 97491 molecular weight